![Frank Holler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Holler
Président chez
DELIVRA HEALTH BRANDS INC.
Fortune : 88 918 $ au 31/07/2026
Profil
Mr. Frank A. Holler is an Independent Director at Rakovina Therapeutics, Inc., an Executive Chairman at Delivra Health Brands, Inc., a President & Chief Executive Officer at Ponderosa Capital, Inc. and a Chairman at PROOF Centre of Excellence.
He is on the Board of Directors at Rakovina Therapeutics, Inc. and PheroTech International, Inc. Mr. Holler was previously employed as a Chairman by Theratechnologies, Inc., an Executive Chairman by Sernova Corp., an Independent Director by Allon Therapeutics, Inc., a Chairman & Chief Executive Officer by BC Advantage Funds Ltd., a Co-Founder, Chairman & Chief Executive Officer by Lions Capital Corp., a Chief Executive Officer by Prime Trials Ltd., an Independent Director by Protox Therapeutics, Inc., an Independent Director by Xenon Pharmaceuticals, Inc., a President & Chief Executive Officer by ID Biomedical Corp., a Vice President-Investment Banking by Merrill Lynch Canada, Inc., a Vice President-Investment Banking by CIBC World Markets Corp.
(Old), a Chief Executive Officer by BC Advantage Funds Ltd., a Chairman by BIRC Corp., a Chairman by Emerillon Therapeutics, Inc., a Chairman & Chief Executive Officer by Lions Investment Management Ltd., and a Vice Chairman by Providence Health Care (Vancouver).
He also served on the board at Aquinox Pharmaceuticals, Inc., Contech Enterprises, Inc., Genome British Columbia, Angiotech Pharmaceuticals, Inc., British Columbia Biotechnology Association, LifeSciences British Columbia, CANTEST Ltd., In Motion Technology, Inc. and Redlen Technologies, Inc. He received his undergraduate degree from the University of British Columbia and an MBA from the University of British Columbia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/11/2025 | 1 071 300 ( 3,43 % ) | 88 918 $ | 31/07/2026 |
Postes actifs de Frank Holler
| Sociétés | Poste | Début |
|---|---|---|
| DELIVRA HEALTH BRANDS INC. | Président | 14/12/2018 |
| RAKOVINA THERAPEUTICS INC. | Directeur/Membre du Conseil | 27/01/2026 |
Ponderosa Capital, Inc.
 Ponderosa Capital, Inc. Investment ManagersFinance Provides capital market and corporate advisory services | Directeur Général | 01/05/2003 |
PROOF Centre of Excellence | Président | 28/07/2014 |
PheroTech International, Inc.
 PheroTech International, Inc. Chemicals: AgriculturalProcess Industries Develops semiochemical and non-toxic insect trapping technology | Directeur/Membre du Conseil | - |
Anciens postes connus de Frank Holler
| Sociétés | Poste | Fin |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Président | 30/05/2023 |
| XENON PHARMACEUTICALS INC. | Fondateur | 01/06/2021 |
Contech Enterprises, Inc.
 Contech Enterprises, Inc. Chemicals: AgriculturalProcess Industries Manufactures pest control and pet training products | Directeur/Membre du Conseil | 06/03/2015 |
Redlen Technologies, Inc.
 Redlen Technologies, Inc. SemiconductorsElectronic Technology Manufactures resolution cadmium zinc telluride semiconductor radiation detectors | Directeur/Membre du Conseil | 06/03/2014 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Frank Holler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
30
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 30 |
|---|---|
CIBC World Markets Corp. (Old)
 CIBC World Markets Corp. (Old) Financial ConglomeratesFinance Provides financial services | Finance |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Health Technology |
Merrill Lynch Canada, Inc.
 Merrill Lynch Canada, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Theratechnologies, Inc.
 Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
BC Advantage Funds Ltd.
 BC Advantage Funds Ltd. Investment ManagersFinance BC Advantage Funds (VCC) Ltd invests invests in emerging life science, technology and clean companies located in British Columbia. Its portfolio includes investments in biotech and medical devices as well as information technology, manufacturing and clean technology companies. The firm makes investments in private and public companies. It invests in early stage transactions. | Finance |
Lions Investment Management Ltd.
 Lions Investment Management Ltd. Investment ManagersFinance Lions Investment Management (LIM) employs an active, flexible and opportunistic investment strategy that seeks to generate long-term positive returns across a variety of market environments, while minimizing risk. The firm utilizes a bottom-up security selection approach that focuses on event-driven situations, undervalued securities and special situations. In managing their funds, LIM uses 4 main strategies: (1) merger arbitrage (2) long positions with targeted events/catalysts (3) short positions with targeted events/catalysts and (4) pair trades. The firm looks for investment opportunities in which they can clearly identify an expected catalyst that will generate a change in a security's price. LIM invests primarily in the stocks of US and Canadian companies, with a small/mid-cap bias. | Finance |
BIRC Corp.
 BIRC Corp. Investment Trusts/Mutual FundsMiscellaneous Investment firm focused on the biopharmaceutical contract research industry | Miscellaneous |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Allon Therapeutics, Inc.
 Allon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to protect against neurodegenerative conditions | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CANTEST Ltd.
 CANTEST Ltd. Miscellaneous Commercial ServicesCommercial Services Provides analytical testing and consultation services | Commercial Services |
Prime Trials Ltd.
 Prime Trials Ltd. Miscellaneous Commercial ServicesCommercial Services Operates clinical laboratories | Commercial Services |
Emerillon Therapeutics, Inc.
 Emerillon Therapeutics, Inc. BiotechnologyHealth Technology Used to develop genomics-based drugs for human complex diseases | Health Technology |
PheroTech International, Inc.
PheroTech International, Inc. Chemicals: AgriculturalProcess Industries Develops semiochemical and non-toxic insect trapping technology | Process Industries |
Lions Capital Corp.
 Lions Capital Corp. Investment ManagersFinance Lions Capital invests in companies located in Canada. The firm targets companies operating in the fields of technology, life science and clean tech. They provide financing for early stage requirements. | Finance |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Health Technology |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Genome British Columbia
 Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Invests in and manages large-scale genomics and proteomics research projects | Commercial Services |
In Motion Technology, Inc.
 In Motion Technology, Inc. Telecommunications EquipmentElectronic Technology Provides mobile networking systems | Electronic Technology |
Redlen Technologies, Inc.
Redlen Technologies, Inc. SemiconductorsElectronic Technology Manufactures resolution cadmium zinc telluride semiconductor radiation detectors | Electronic Technology |
Contech Enterprises, Inc.
Contech Enterprises, Inc. Chemicals: AgriculturalProcess Industries Manufactures pest control and pet training products | Process Industries |
PROOF Centre of Excellence | |
Providence Health Care (Vancouver)
 Providence Health Care (Vancouver) Hospital/Nursing ManagementHealth Services Functions as non profit healthcare organization that operates hospital | Health Services |
Delivra Health Brands, Inc.
 Delivra Health Brands, Inc. Agricultural Commodities/MillingProcess Industries Produces medical marijuana | Process Industries |
Ponderosa Capital, Inc.
Ponderosa Capital, Inc. Investment ManagersFinance Provides capital market and corporate advisory services | Finance |
Rakovina Therapeutics, Inc.
 Rakovina Therapeutics, Inc. Financial ConglomeratesFinance Develops oncology therapeutics | Finance |
British Columbia Biotechnology Association |
